-

01:56:50 AM

DMTTF Stock News

DMTTF - Small Pharma Inc

02/01/23 7:50 AM

OTC : DMTTF

Small Pharma Announces Update on Intellectual Property Portfolio with Two New Patents Approved for Issue

Small Pharma Inc. (TSXV: DMT)

RHEA-AI

very positive

01/25/23 7:05 AM

OTC : DMTTF

earnings

Small Pharma Reports Fiscal Third Quarter 2023 Highlights

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma

RHEA-AI

very positive

01/25/23 6:00 AM

OTC : DMTTF

Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder

First placebo-controlled efficacy study completed to date exploring a short-duration psychedelic for depression demonstrates rapid and durable response Primary endpoint met with a statistically significant -7.4 point difference between SPL026 (21.5mg) and placebo at two-weeks post-dose as measured

RHEA-AI

neutral

01/24/23 4:00 PM

OTC : DMTTF

Small Pharma To Announce Results of SPL026 Phase IIa Trial for Major Depressive Disorder and Host Conference Call on Wednesday, January 25

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today announces that it will release top-line data from its

RHEA-AI

neutral

01/09/23 7:50 AM

OTC : DMTTF

First Patient Dosed in Small Pharma’s Phase I Study Exploring Intramuscular Administration of SPL026

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for

RHEA-AI

neutral

12/22/22 7:46 AM

OTC : DMTTF

Small Pharma Announces Completion of SPL026 Phase IIa Trial and Secures New Intellectual Property

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “

RHEA-AI

very positive

12/15/22 7:50 AM

OTC : DMTTF

First Patient Dosed in Small Pharma’s Drug Interaction Study

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for

RHEA-AI

neutral

12/14/22 7:50 AM

OTC : DMTTF

Small Pharma To Support University College London Research Project on Neuroplasticity

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a

RHEA-AI

neutral

12/08/22 5:00 PM

OTC : DMTTF

conferences

Small Pharma to Participate in Upcoming Canaccord Genuity Investor Symposium

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, is pleased to announce that George Tziras, Chief Executive

RHEA-AI

neutral

11/11/22 7:50 AM

OTC : DMTTF

conferences

Small Pharma to Participate in November Investor and Healthcare Conferences

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, is pleased to announce its participation in the following

RHEA-AI

neutral